These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

430 related articles for article (PubMed ID: 31122192)

  • 1. Causative agents and outcome of spontaneous bacterial peritonitis in cirrhotic patients: community-acquired versus nosocomial infections.
    Ding X; Yu Y; Chen M; Wang C; Kang Y; Lou J
    BMC Infect Dis; 2019 May; 19(1):463. PubMed ID: 31122192
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pathogen profile and drug resistance analysis of spontaneous peritonitis in cirrhotic patients.
    Li YT; Yu CB; Huang JR; Qin ZJ; Li LJ
    World J Gastroenterol; 2015 Sep; 21(36):10409-17. PubMed ID: 26420967
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical significance and outcome of nosocomial acquisition of spontaneous bacterial peritonitis in patients with liver cirrhosis.
    Cheong HS; Kang CI; Lee JA; Moon SY; Joung MK; Chung DR; Koh KC; Lee NY; Song JH; Peck KR
    Clin Infect Dis; 2009 May; 48(9):1230-6. PubMed ID: 19302016
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Microbiology and resistance in first episodes of spontaneous bacterial peritonitis: implications for management and prognosis.
    Friedrich K; Nüssle S; Rehlen T; Stremmel W; Mischnik A; Eisenbach C
    J Gastroenterol Hepatol; 2016 Jun; 31(6):1191-5. PubMed ID: 26676553
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nosocomial and Community-Acquired Spontaneous Bacterial Peritonitis in patients with liver cirrhosis in China: Comparative Microbiology and Therapeutic Implications.
    Shi L; Wu D; Wei L; Liu S; Zhao P; Tu B; Xie Y; Liu Y; Wang X; Liu L; Zhang X; Xu Z; Wang F; Qin E
    Sci Rep; 2017 Apr; 7():46025. PubMed ID: 28382951
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Extensively drug-resistant bacteria are an independent predictive factor of mortality in 130 patients with spontaneous bacterial peritonitis or spontaneous bacteremia.
    Alexopoulou A; Vasilieva L; Agiasotelli D; Siranidi K; Pouriki S; Tsiriga A; Toutouza M; Dourakis SP
    World J Gastroenterol; 2016 Apr; 22(15):4049-56. PubMed ID: 27099449
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparative study on nosocomial and community-acquired spontaneous bacterial peritonitis in patients with liver cirrhosis at a university hospital.
    ELshamy RM; Oda MS; Saeed MA; Ramadan RA
    Eur J Gastroenterol Hepatol; 2022 Jun; 34(6):655-663. PubMed ID: 35352700
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antibiotic resistance in healthcare-related and nosocomial spontaneous bacterial peritonitis.
    Lutz P; Nischalke HD; Krämer B; Goeser F; Kaczmarek DJ; Schlabe S; Parcina M; Nattermann J; Hoerauf A; Strassburg CP; Spengler U
    Eur J Clin Invest; 2017 Jan; 47(1):44-52. PubMed ID: 27861767
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic significance of infection acquisition sites in spontaneous bacterial peritonitis: nosocomial versus community acquired.
    Song JY; Jung SJ; Park CW; Sohn JW; Kim WJ; Kim MJ; Cheong HJ
    J Korean Med Sci; 2006 Aug; 21(4):666-71. PubMed ID: 16891810
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Are third-generation cephalosporins still the empirical antibiotic treatment of community-acquired spontaneous bacterial peritonitis? A systematic review and meta-analysis.
    Fiore M; Gentile I; Maraolo AE; Leone S; Simeon V; Chiodini P; Pace MC; Gustot T; Taccone FS
    Eur J Gastroenterol Hepatol; 2018 Mar; 30(3):329-336. PubMed ID: 29303883
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nosocomial and community-acquired spontaneous bacterial peritonitis: comparative microbiology and therapeutic implications.
    Bert F; Andreu M; Durand F; Degos F; Galdbart JO; Moreau R; Branger C; Lambert-Zechovsky N; Valla D
    Eur J Clin Microbiol Infect Dis; 2003 Jan; 22(1):10-5. PubMed ID: 12582738
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Community-acquired vs. nosocomial spontaneous bacterial peritonitis in patients with liver cirrhosis.
    Chon YE; Kim SU; Lee CK; Park JY; Kim DY; Han KH; Chon CY; Kim S; Jung KS; Ahn SH
    Hepatogastroenterology; 2014; 61(136):2283-90. PubMed ID: 25741536
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multi-resistant bacteria in spontaneous bacterial peritonitis: a new step in management?
    de Mattos AA; Costabeber AM; Lionço LC; Tovo CV
    World J Gastroenterol; 2014 Oct; 20(39):14079-86. PubMed ID: 25339797
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk factors for resistance to ceftriaxone and its impact on mortality in community, healthcare and nosocomial spontaneous bacterial peritonitis.
    Ariza X; Castellote J; Lora-Tamayo J; Girbau A; Salord S; Rota R; Ariza J; Xiol X
    J Hepatol; 2012 Apr; 56(4):825-32. PubMed ID: 22173153
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical impact of healthcare-associated acquisition in cirrhotic patients with community-onset spontaneous bacterial peritonitis.
    Kim J; Kang CI; Gwak GY; Chung DR; Peck KR; Song JH
    Korean J Intern Med; 2020 Jan; 35(1):215-221. PubMed ID: 29502362
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evidence of Significant Ceftriaxone and Quinolone Resistance in Cirrhotics with Spontaneous Bacterial Peritonitis.
    Ardolino E; Wang SS; Patwardhan VR
    Dig Dis Sci; 2019 Aug; 64(8):2359-2367. PubMed ID: 30761472
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The empirical antibiotic treatment of nosocomial spontaneous bacterial peritonitis: Results of a randomized, controlled clinical trial.
    Piano S; Fasolato S; Salinas F; Romano A; Tonon M; Morando F; Cavallin M; Gola E; Sticca A; Loregian A; Palù G; Zanus G; Senzolo M; Burra P; Cillo U; Angeli P
    Hepatology; 2016 Apr; 63(4):1299-309. PubMed ID: 26084406
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predictive factors that influence the survival rates in liver cirrhosis patients with spontaneous bacterial peritonitis.
    Tsung PC; Ryu SH; Cha IH; Cho HW; Kim JN; Kim YS; Moon JS
    Clin Mol Hepatol; 2013 Jun; 19(2):131-9. PubMed ID: 23837137
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Unsolved Issues in the Treatment of Spontaneous Peritonitis in Patients with Cirrhosis: Nosocomial Versus Community-acquired Infections and the Role of Fungi.
    Maraolo AE; Buonomo AR; Zappulo E; Scotto R; Pinchera B; Gentile I
    Rev Recent Clin Trials; 2019; 14(2):129-135. PubMed ID: 30514194
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical and microbiological profiles of community-acquired and nosocomial intra-abdominal infections: results of the French prospective, observational EBIIA study.
    Montravers P; Lepape A; Dubreuil L; Gauzit R; Pean Y; Benchimol D; Dupont H
    J Antimicrob Chemother; 2009 Apr; 63(4):785-94. PubMed ID: 19196742
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.